Citigroup’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,751
| Closed | -$16K | – | 5333 |
|
|
2019
Q4 | $16K | Buy |
4,751
+3,146
| +196% | +$10.6K | ﹤0.01% | 4576 |
|
|
2019
Q3 | $5K | Buy |
1,605
+340
| +27% | +$1.06K | ﹤0.01% | 4820 |
|
|
2019
Q2 | $3K | Buy |
1,265
+442
| +54% | +$1.05K | ﹤0.01% | 4978 |
|
|
2019
Q1 | $3K | Buy |
+823
| New | +$3K | ﹤0.01% | 4953 |
|
|
2017
Q2 | – | Sell |
-1,054
| Closed | -$5K | – | 5058 |
|
|
2017
Q1 | $5K | Sell |
1,054
-2,258
| -68% | -$10.7K | ﹤0.01% | 4494 |
|
|
2016
Q4 | $37K | Sell |
3,312
-2,688
| -45% | -$30K | ﹤0.01% | 4232 |
|
|
2016
Q3 | $56K | Buy |
6,000
+344
| +6% | +$3.21K | ﹤0.01% | 3677 |
|
|
2016
Q2 | $36K | Sell |
5,656
-18,818
| -77% | -$120K | ﹤0.01% | 3872 |
|
|
2016
Q1 | $160K | Buy |
24,474
+13,404
| +121% | +$87.6K | ﹤0.01% | 3656 |
|
|
2015
Q4 | $90K | Buy |
11,070
+11,066
| +276,650% | +$90K | ﹤0.01% | 3661 |
|
|
2015
Q3 | $0 | Sell |
4
-3,157
| -100% | – | ﹤0.01% | 5735 |
|
|
2015
Q2 | $32K | Buy |
+3,161
| New | +$32K | ﹤0.01% | 4007 |
|
|
2015
Q1 | – | Sell |
-62
| Closed | – | – | 5767 |
|
|
2014
Q4 | $0 | Buy |
+62
| New | – | ﹤0.01% | 5702 |
|